Farfán-Castillo Angie de Los Milagros, Moreno-Núñez Rosangela Simone, Zárate-Yuyes Fátima Milagros, Fernández-Rodríguez Lissett Jeanette, Bardales-Zuta Victor Hugo
School of Human Medicine, Antenor Orrego Private University, Trujillo, PER.
Cureus. 2022 Nov 23;14(11):e31836. doi: 10.7759/cureus.31836. eCollection 2022 Nov.
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, created a rapidly unfolding health crisis, especially in the initial phases of the pandemic. In the early stages of the pandemic, various strategies were proposed for COVID-19 prophylaxis and treatment with very little scientific evidence available. Among these proposed treatments were ivermectin and chlorine dioxide, which were both used widely in Peru for both disease prevention and treatment without considering their problematic side effects. For instance, ivermectin was part of an approved therapeutic scheme based on in vitro data, although its efficacy in humans was not demonstrated. In addition, chlorine dioxide was never shown to be effective but causes threatening side effects. In this article, we discuss current information regarding chlorine dioxide and ivermectin in the context of the COVID-19 pandemic, with a focus on experiences in Peru.
严重急性呼吸综合征冠状病毒2（SARS-CoV-2），即导致新冠肺炎的病毒，引发了一场迅速演变的健康危机，尤其是在疫情初期。在疫情早期，人们提出了各种新冠肺炎预防和治疗策略，但几乎没有科学证据。在这些提议的治疗方法中，有伊维菌素和二氧化氯，它们在秘鲁都被广泛用于疾病预防和治疗，而没有考虑其存在问题的副作用。例如，伊维菌素是基于体外数据的批准治疗方案的一部分，尽管其对人类的疗效尚未得到证实。此外，二氧化氯从未被证明有效，但会导致危险的副作用。在本文中，我们将在新冠肺炎疫情背景下讨论有关二氧化氯和伊维菌素的当前信息，重点是秘鲁的经验。
